<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Antibodies to Epstein-Barr virus associated cell membrane antigens persisted or slowly decreased during prolonged uncomplicated survival of patients with Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in remission </plain></SENT>
<SENT sid="1" pm="."><plain>Serum was sampled from four patients within 6 months before recurrence occurring after the first year and preceded by remission during more than 6 months </plain></SENT>
<SENT sid="2" pm="."><plain>Rapid and significant decreases of the antibodies before clinical recognition of the recurrences were found in three patients </plain></SENT>
<SENT sid="3" pm="."><plain>The fourth patient had slowly increasing titers before relapse </plain></SENT>
<SENT sid="4" pm="."><plain>Immune stimulant treatment during remission, with BCG (Bacille Calmette Gu√©rin vaccine) or BCG + Bordetella <z:e sem="disease" ids="C0043167" disease_type="Disease or Syndrome" abbrv="">pertussis</z:e>, temporarily increased the antibody levels </plain></SENT>
<SENT sid="5" pm="."><plain>Possible mechanisms for the observed titer changes before recurrence are discussed </plain></SENT>
</text></document>